362 related articles for article (PubMed ID: 19607882)
1. The role of protein O-linked beta-N-acetylglucosamine in mediating cardiac stress responses.
Chatham JC; Marchase RB
Biochim Biophys Acta; 2010 Feb; 1800(2):57-66. PubMed ID: 19607882
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection by N-acetylglucosamine linkage to cellular proteins.
Jones SP; Zachara NE; Ngoh GA; Hill BG; Teshima Y; Bhatnagar A; Hart GW; Marbán E
Circulation; 2008 Mar; 117(9):1172-82. PubMed ID: 18285568
[TBL] [Abstract][Full Text] [Related]
3. Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.
Laczy B; Hill BG; Wang K; Paterson AJ; White CR; Xing D; Chen YF; Darley-Usmar V; Oparil S; Chatham JC
Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H13-28. PubMed ID: 19028792
[TBL] [Abstract][Full Text] [Related]
4. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.
Fülöp N; Marchase RB; Chatham JC
Cardiovasc Res; 2007 Jan; 73(2):288-97. PubMed ID: 16970929
[TBL] [Abstract][Full Text] [Related]
5. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc.
Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C178-87. PubMed ID: 16899550
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins.
Wu T; Zhou H; Jin Z; Bi S; Yang X; Yi D; Liu W
Eur J Pharmacol; 2009 Jun; 613(1-3):93-9. PubMed ID: 19376110
[TBL] [Abstract][Full Text] [Related]
7. The Role of O-GlcNAcylation for Protection against Ischemia-Reperfusion Injury.
Jensen RV; Andreadou I; Hausenloy DJ; Bøtker HE
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669312
[TBL] [Abstract][Full Text] [Related]
8. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.
Liu J; Marchase RB; Chatham JC
J Mol Cell Cardiol; 2007 Jan; 42(1):177-85. PubMed ID: 17069847
[TBL] [Abstract][Full Text] [Related]
9. Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.
Darley-Usmar VM; Ball LE; Chatham JC
J Mol Cell Cardiol; 2012 Mar; 52(3):538-49. PubMed ID: 21878340
[TBL] [Abstract][Full Text] [Related]
10. The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
Love DC; Hanover JA
Sci STKE; 2005 Nov; 2005(312):re13. PubMed ID: 16317114
[TBL] [Abstract][Full Text] [Related]
11. Protein O-GlcNAcylation: A critical regulator of the cellular response to stress.
Chatham JC; Marchase RB
Curr Signal Transduct Ther; 2010 Jan; 5(1):49-59. PubMed ID: 22308107
[TBL] [Abstract][Full Text] [Related]
12. Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart.
McLarty JL; Marsh SA; Chatham JC
Life Sci; 2013 Mar; 92(11):621-7. PubMed ID: 22985933
[TBL] [Abstract][Full Text] [Related]
13. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.
Chatham JC; Nöt LG; Fülöp N; Marchase RB
Shock; 2008 Apr; 29(4):431-40. PubMed ID: 17909453
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAcylation and cardiovascular disease.
Wright JN; Collins HE; Wende AR; Chatham JC
Biochem Soc Trans; 2017 Apr; 45(2):545-553. PubMed ID: 28408494
[TBL] [Abstract][Full Text] [Related]
15. Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications.
Chatham JC; Young ME; Zhang J
Curr Opin Pharmacol; 2021 Apr; 57():1-12. PubMed ID: 32937226
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAc signaling in the cardiovascular system.
Ngoh GA; Facundo HT; Zafir A; Jones SP
Circ Res; 2010 Jul; 107(2):171-85. PubMed ID: 20651294
[TBL] [Abstract][Full Text] [Related]
17. Role of the O-linked β-N-acetylglucosamine in the cardioprotection induced by isoflurane.
Hirose K; Tsutsumi YM; Tsutsumi R; Shono M; Katayama E; Kinoshita M; Tanaka K; Oshita S
Anesthesiology; 2011 Nov; 115(5):955-62. PubMed ID: 21876430
[TBL] [Abstract][Full Text] [Related]
18. Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury.
Ngoh GA; Facundo HT; Hamid T; Dillmann W; Zachara NE; Jones SP
Circ Res; 2009 Jan; 104(1):41-9. PubMed ID: 19023128
[TBL] [Abstract][Full Text] [Related]
19. Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes.
Zhu-Mauldin X; Marsh SA; Zou L; Marchase RB; Chatham JC
J Biol Chem; 2012 Nov; 287(46):39094-106. PubMed ID: 22992728
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ALDH2 by O-GlcNAcylation contributes to the hyperglycemic exacerbation of myocardial ischemia/reperfusion injury.
Liu B; Wang J; Li M; Yuan Q; Xue M; Xu F; Chen Y
Oncotarget; 2017 Mar; 8(12):19413-19426. PubMed ID: 28038474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
